行情

NVTA

NVTA

Invitae
NYSE

实时行情|Nasdaq Last Sale

11.71
-1.96
-14.34%
盘后: 10.49 -1.22 -10.42% 19:58 04/01 EDT
开盘
12.57
昨收
13.67
最高
13.27
最低
11.70
成交量
234.15万
成交额
--
52周最高
28.75
52周最低
7.42
市值
11.59亿
市盈率(TTM)
-4.4642
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NVTA价格均价为31.08,最高价位32.00,最低价为30.00。

EPS

NVTA 新闻

更多
  • Invitae Announces Proposed Public Offering of Common Stock
  • PR Newswire · 10小时前
  • Invitae Corp To Withdraw Its Revenue, Test Volume And Cash Burn Guidance For 2020
  • Reuters · 10小时前
  • Hearing Invitae Shares Via Offering Priced At $9/Share
  • Bloomberg · 10小时前
  • Invitae Announces $125M Common Stock Offering
  • Benzinga · 11小时前

所属板块

生物技术和医学研究
-4.52%
制药与医学研究
-2.91%

热门股票

代码
价格
涨跌幅

NVTA 简况

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The Company offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company focuses on genetic testing, genome network and genome management. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The Company holds interests in AltaVoice, a patient-centered data company.
展开

微牛提供InVitae Corp(NYSE-NVTA)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NVTA股票新闻,以帮助您做出投资决策。